Professional Documents
Culture Documents
Natural History of AR
Onset is common in childhood, adolescence and early adulthood Symptoms often wane in older adults, but may develop or persist at any age No apparent gender selectivity or predisposition for developing allergic rhinitis May contribute to other conditions such as Sleep disorders Fatigue Learning problems
Causes of AR
Irritation of free nerve endings---- Itching and sneezing Increased mucus production -----Vasodilation -------- Congestion
Rhinorrhoea
Oedema
Clinical Manifestations
Others
Nasal congestion
ARIA Classification
Intermittent
< 4 days per week or < 4 weeks
Persistent
4 days per week and 4 weeks
Mild
normal sleep & no impairment of daily activities, sport, leisure & normal work and school & no troublesome symptoms
Moderate-severe
one or more items
abnormal sleep impairment of daily activities, sport, leisure abnormal work and school troublesome symptoms
10
1
0,1
10
Symptoms inflammation
Diagnosis of AR
History Physical / Nasal Examination Laboratory Testing - Skin Prick Test - Peak Nasal Inspiratory Flow Rate - Rhinomanometry
PHYSICAL EXAMINATION
Allergic shiner Dennie Morgan line Allergic crease Allergic salute Nasal mucosa may appear normal or pale bluish, swollen with watery secretions but only if patient is symptomatic Exclude structural problems (polyps, deflected nasal septum)
Others:
nasal voice, constant mouth breathing, frequent snoring, coughing, repetitive sneezing, chronic open gape of the mouth, weakness, malaise, irritability
Management of AR
Pharmacotherapy
Medications used to treat allergic rhinits:
Antihistamines Decongestants AH-D combinations Corticosteroids Mast Cell stabilizers Anticholinergics Antileukotrienes
Corticosteroids
Decongestants Mast cell stabiliser
Antileukotrienes
+++++
0 +++++
+++++
0 +++
+++
+ +
+++
+++++ 0
+++
++
++++
Anti-Histamines
Act by preventing histamine from binding to the H1-receptors Primarily helpful in controlling Sneezing, itching & rhinorrhoea; ineffective in releiving nasal blockage 1st generation anti-histamines - chlorpheniramine - diphenylhydramine 2nd generation anti-histamines - cetrizine - azelastine - fexofenadine - loratadine
Potent topical activity Administration of low doses directly at site of action Considerable efficacy at low doses High topical: systemic activity ratios Rapid first-pass hepatic metabolism of any systemically absorbed drug, to compounds with negligible activity Markedly greater inhibition of EAR than with oral steroids
The Ideal Drug For Allergic Rhinitis Should Have The Following Features:
Inhibit both early and late phases Be an H1 blocker Counter effects of other mediators Fast-acting, to control the early phase Dosing-od or bd for compliance No side effects Manage all symptoms Intranasal administration
JACI 1999; 103:S388
Moderate-severe
Oral H1 blocker and/or LTRA Intranasal H1 blocker and/or decongestant Intranasal CS
Moderate-severe
Intranasal CS If nose very blocked add oral CS or decongestant or LTRA